| |
 |
|
Class Information
Number: 424/186.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus
Description: Subject matter wherein the disclosed amino acid sequence is derived from a viral protein or fragment thereof.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6361778 |
Carboxyl terminal of papillomavirus L1 region is not required for formation of virus-like particles |
Mar. 26, 2002 |
| 6358512 |
Feline infectious peritonitis vaccine |
Mar. 19, 2002 |
| 6355246 |
Feline calicivirus isolated from cat urine and vaccines thereof |
Mar. 12, 2002 |
| 6352696 |
Papillomavirus truncated L1 protein and fusion protein constructs |
Mar. 5, 2002 |
| 6350854 |
Isolated 55 to 72 kDa protein which binds to prion proteins |
Feb. 26, 2002 |
| 6348586 |
Unique associated Kaposi's sarcoma virus sequences and uses thereof |
Feb. 19, 2002 |
| 6342222 |
Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
Jan. 29, 2002 |
| 6342224 |
Recombinant papillomavirus vaccine and method for production and treatment |
Jan. 29, 2002 |
| 6337070 |
Polypeptides for use in generating anti-human influenza virus antibodies |
Jan. 8, 2002 |
| 6335016 |
Chicken embryo lethal orphan (CELO) virus |
Jan. 1, 2002 |
| 6326009 |
Enhancement of the cellular immune response |
Dec. 4, 2001 |
| 6322794 |
Seroreactive epitopes on proteins of human papillomavirus (HPV) 18 |
Nov. 27, 2001 |
| 6312696 |
Antigenic protein originating in infectious laryngotracheitis virus |
Nov. 6, 2001 |
| 6309647 |
Poxvirus--canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
Oct. 30, 2001 |
| 6306397 |
Variants of human papilloma virus antigens |
Oct. 23, 2001 |
| 6296852 |
Recombinant avian adenovirus vector |
Oct. 2, 2001 |
| 6290965 |
DNA encoding human papillomavirus type 6A |
Sep. 18, 2001 |
| 6287565 |
Modified HGP-30 heteroconjugates, compositions and methods of use |
Sep. 11, 2001 |
| 6287572 |
Anti-HIV peptides and proteins |
Sep. 11, 2001 |
| 6287856 |
Vaccines against circovirus infections |
Sep. 11, 2001 |
| 6284249 |
Fusion polypeptide having the C protein and E1 protein of hepatitis C virus |
Sep. 4, 2001 |
| 6280974 |
Recombinant feline coronavirus S proteins |
Aug. 28, 2001 |
| 6261563 |
Pseudorabies virus protein |
Jul. 17, 2001 |
| 6261806 |
Molecular sequence of swine retrovirus and methods of use |
Jul. 17, 2001 |
| 6261535 |
Diagnostic methods for targeting the vasculature of solid tumors |
Jul. 17, 2001 |
| 6251397 |
Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same |
Jun. 26, 2001 |
| 6251398 |
Materials and methods for intracellular transport and their uses |
Jun. 26, 2001 |
| 6251399 |
Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
Jun. 26, 2001 |
| 6242567 |
Method for detection and prevention of human cytomegalovirus infection |
Jun. 5, 2001 |
| 6238669 |
Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
May. 29, 2001 |
| 6235284 |
Synthetic polypeptides belonging to the hepatitis C virus (HCV) and which can be used especially for detecting the latter |
May. 22, 2001 |
| 6235523 |
Vectors for DNA immunization against cervical cancer |
May. 22, 2001 |
| 6231863 |
DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
May. 15, 2001 |
| 6228368 |
Papilloma virus capsomere formulations and method of use |
May. 8, 2001 |
| 6228983 |
Human respiratory syncytial virus peptides with antifusogenic and antiviral activities |
May. 8, 2001 |
| 6224879 |
Alphavirus expression vector |
May. 1, 2001 |
| 6221577 |
Seroreactive regions on HPV 16-proteins E1 and E2 |
Apr. 24, 2001 |
| 6210675 |
PT-NANB hepatitis polypeptides |
Apr. 3, 2001 |
| 6210682 |
Rotavirus enterotoxin NSP4 and methods of using same |
Apr. 3, 2001 |
| 6210901 |
Specific binding substances for antibodies and their use for immunoassays or vaccines |
Apr. 3, 2001 |
| 6207161 |
Induction of cytolytic T-lymphocytes with cytomegalovirus polypeptides |
Mar. 27, 2001 |
| 6200576 |
Swine vesicular disease virus and mutant strains and preparation process and use thereof |
Mar. 13, 2001 |
| 6197749 |
Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
Mar. 6, 2001 |
| 6194560 |
Oral immunization with transgenic plants |
Feb. 27, 2001 |
| 6193983 |
Equine herpesvirus glycoproteins |
Feb. 27, 2001 |
| 6183750 |
Avipox virus containing DNA sequences encoding herpesvirus glycoproteins |
Feb. 6, 2001 |
| 6183746 |
Immunogenic peptides from the HPV E7 protein |
Feb. 6, 2001 |
| 6180758 |
Synthetic peptides for rubella vaccine |
Jan. 30, 2001 |
| 6177080 |
Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
Jan. 23, 2001 |
| 6174528 |
Synthetic peptides and vaccines comprising same |
Jan. 16, 2001 |
|
|
|
